Drugs / BIS-001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05102552 Comparator | Oct 2021 → Mar 2022 | — | Supernus Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIS-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05102552 ↗ |
| Action | Inhibit | “an acetylcholinesterase inhibitor” NCT05102552 ↗ |